• FY26 revenue up 12.4% to $1,974.9 million
• Supply chain disruption impacted 2H26 results
• Declared $300 million special dividend and increased ordinary dividends
• FY27 outlook: revenue growth expected, IMF sales to recover gradually
• Strategic focus on innovation, new markets, and supply chain transformation

The a2 Milk Company Limited announced its FY26 results, reporting a revenue increase of 12.4% to $1,974.9 million. The company achieved double-digit growth in Infant Milk Formula (IMF) and Other Nutritionals, although supply chain disruptions in 4Q26 impacted overall performance. The company declared a $300 million special dividend and increased ordinary dividends. Looking ahead, the company expects revenue growth in FY27, supported by product innovation, new markets, and the recovery of IMF sales. The company remains focused on capturing China IMF potential, ramping up innovation, entering new markets, and transforming its supply chain.

FY27 revenue growth expected, EBITDA margin approximately 15%

The company expects revenue and EBITDA growth in FY27, supported by increased contribution from product innovation, new markets, and continued momentum in Other Nutritionals and Liquid Milk. IMF sales are expected to be impacted by the flow-on effects of supply chain disruption in 4Q26.